Odonate

(OTC) ODT

Current PriceN/A

Market CapN/A

Since IPO (2017)-92%

5 Year-95%

1 Year+17%

1 Month+10%

Odonate Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$102.07M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Nov 10, 2021

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Nov 10, 2021

ODT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Odonate

Industry

Pharmaceuticals

Sector

Health Care

CEO

Kevin C. Tang

Website

www.odonate.com

Headquarters

San Diego, CA 10016, US

ODT Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-1%

Return on Assets

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$127.43M

EBITDA

-$126.99M

Operating Cash Flow

-$113.13M

Capital Expenditure

-$432.00K

Free Cash Flow

-$113.56M

Cash & ST Invst.

$157.27M

Total Debt

$5.33M

Odonate Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2021YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

137

N/A

Net Income

-$14.00M

+54.1%

EBITDA

-$13.88M

+54.5%

Quarterly Fundamentals

Name

Q3 2021YOY CHG

Total Cash

$95.03M

-49.5%

Total Debt

$4.85M

-9.8%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$4.11M

N/A

Short Term Debt

$744.00K

N/A

Return on Assets

6.63%

N/A

Return on Invested Capital

-0.74%

N/A

Free Cash Flow

-$15.10M

+40.4%

Operating Cash Flow

-$15.10M

+40.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MGTAMagenta Therapeutics, Inc.

MGTAMagenta Therapeutics, Inc.$0.70-7.74%

GRNAGreenLight Biosciences Holdings

GRNAGreenLight Biosciences Holdings$0.30-0.03%

PSTIPluristem Therapeutics Inc.

PSTIPluristem Therapeutics Inc.$1.00-2.91%

RNTXRein Therapeutics Inc.

RNTXRein Therapeutics Inc.$0.96+3.49%

EYENEyenovia, Inc.

EYENEyenovia, Inc.$7.56+3.99%

BLUEbluebird bio, Inc.

BLUEbluebird bio, Inc.$4.97+0.00%

SYRESpyre Therapeutics, Inc.

SYRESpyre Therapeutics, Inc.$80.79+0.02%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

RKLBRocket Lab

RKLBRocket Lab$102.39-0.11%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About ODT

What is the current price of Odonate?

Odonate is trading at N/A per share.

What is the 52-week range for Odonate?

Over the past 52 weeks, Odonate has traded between N/A and N/A.

How much debt does Odonate have?

As of the most recent reporting period, Odonate reported total debt of $2.30M.

How much cash does Odonate have on hand?

Odonate reported $39.54M in cash and cash equivalents in its most recent financial results.

What is Odonate’s dividend yield?

Odonate does not currently have a dividend yield.

Odonate

Odonate Financials at a Glance

ODT News

Why Odonate Therapeutics Stock Is Crashing Today

Why Odonate Therapeutics Stock Is Soaring Today

Here's Why Odonate Therapeutics Stock Jumped 70.7% in June

3 Biotech Stocks That Soared This Week: Are They Buys?

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Odonate

ODT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Odonate Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ODT

What is the current price of Odonate?

What is the 52-week range for Odonate?

How much debt does Odonate have?

How much cash does Odonate have on hand?

What is Odonate’s dividend yield?

Premium Investing Services